CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman and CEO arg2" "arg1 Chairman and CEO arg2" "arg1 CEO and chairman arg2" "arg1 president and CEO arg2" "arg1 Chairman and Chief Executive arg2" ] using (lilly, john_lechleiter)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman and CEO arg2" "arg1 Chairman and CEO arg2" "arg1 CEO and chairman arg2" "arg1 president and CEO arg2" "arg1 Chairman and Chief Executive arg2" ] using (john_lechleiter, lilly)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman and CEO arg2" "arg1 Chairman and CEO arg2" "arg1 CEO and chairman arg2" "arg1 president and CEO arg2" "arg1 Chairman and Chief Executive arg2" ] using (lilly, john_lechleiter)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman and CEO arg2" "arg1 Chairman and CEO arg2" "arg1 CEO and chairman arg2" "arg1 president and CEO arg2" "arg1 Chairman and Chief Executive arg2" ] using (john_lechleiter, lilly)
CPL @1097 (93.8%) on 19-jan-2018 [ "arg2 chairman and CEO arg1" "arg2 Chairman and CEO arg1" "arg2 CEO and chairman arg1" "arg2 president and CEO arg1" ] using (john_lechleiter, lilly)
NELL has only weak evidence for items listed in grey
SEAL @236 (75.0%) on 16-apr-2011 [ 12 ] using (alimta, lilly)
CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 by Eli arg2" "arg1 produced by Eli arg2" "arg1 manufacturer Eli arg2" "arg1 is made by Eli arg2" "arg1 manufactured by Eli arg2" "arg1 from Eli arg2" ] using (alimta, lilly)
CPL @1094 (99.8%) on 01-jan-2018 [ "arg1 is manufactured by Eli arg2" "arg1 is produced by Eli arg2" "arg1 from Eli arg2" "arg1 by Eli arg2" "arg1 is marketed by arg2" "arg1 is made by Eli arg2" "arg1 is Eli arg2" "arg1 manufacturer Eli arg2" "arg1 to Eli arg2" ] using (cymbalta, lilly)
SEAL @221 (75.0%) on 18-mar-2011 [ 12 ] using (cymbalta, lilly)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 with Eli arg2" "arg1 is made by Eli arg2" "arg1 is manufactured by Eli arg2" "arg1 made by Eli arg2" "arg1 by Eli arg2" ] using (humalog, lilly)
SEAL @221 (75.0%) on 18-mar-2011 [ 12 ] using (humalog, lilly)
SEAL @241 (87.5%) on 22-apr-2011 [ 123 ] using (prozac, lilly)
OE @823 (89.9%) on 17-mar-2014 [ ] using (prozac, lilly)
CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 from Eli arg2" "arg1 lawsuit against Eli arg2" "arg1 by Eli arg2" "arg1 manufacturer Eli arg2" "arg1 from Eli Lilly and Company arg2" "arg1 is manufactured by Eli arg2" "arg1 made by Eli arg2" "arg1 is Eli arg2" "arg1 with Eli arg2" "arg1 maker Eli arg2" "arg1 is made by Eli arg2" ] using (prozac, lilly)
CPL @1094 (99.6%) on 01-jan-2018 [ "arg1 maker Eli arg2" "arg1 is made by Eli arg2" "arg1 is manufactured by Eli arg2" "arg1 by Eli arg2" "arg1 made by Eli arg2" "arg1 manufactured by Eli arg2" "arg1 to Eli arg2" "arg1 produced by Eli arg2" ] using (strattera, lilly)
SEAL @221 (87.5%) on 18-mar-2011 [ 123 ] using (strattera, lilly)
SEAL @523 (75.0%) on 02-mar-2012 [ 12 ] using (symbyax, lilly)
CPL @1094 (93.8%) on 01-jan-2018 [ "arg1 is manufactured by Eli arg2" "arg1 is made by Eli arg2" "arg1 from Eli arg2" "arg1 maker Eli arg2" ] using (symbyax, lilly)
SEAL @221 (93.8%) on 18-mar-2011 [ 1234 ] using (zyprexa, lilly)
CPL @1094 (100.0%) on 01-jan-2018 [ "arg2 illegally marketed arg1" "arg2 previously argued that arg1" "arg2 illegally promoted arg1" "arg2 played down the risks of arg1" "arg2 concealed information about arg1" "arg2 continued to market arg1" "arg2 downplayed the risks of arg1" "arg2 for its promotion of arg1" "arg2 had failed to disclose arg1" "arg2 aggressively marketed arg1" "arg2 allegedly marketed arg1" "arg2 told doctors that arg1" ] using (zyprexa, lilly)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman and CEO arg1" "arg2 Chairman and CEO arg1" "arg2 CEO and chairman arg1" "arg2 president and CEO arg1" "arg2 Chairman and Chief Executive arg1" ] using (john_lechleiter, lilly)